Moreover, the expression of the regulatory subunit MAT2B is frequently linked to the increase in MAT2A, conferring growth advantage to liver cancer cells [61,121,123,240] and potentially serving as biomarkers. The gene discussed is MAT2A; the disease is liver cancer.